Screener
Protagonist Therapeutics PTGX Operating margin
Operating margin at other companies
Other financials
Where this comes from
Calculated from Protagonist Therapeutics’s reported figures.
Based on trailing twelve months.
The source filing: Protagonist Therapeutics’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 4:17 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-091123
FAQ
- What is Protagonist Therapeutics's operating margin?
- Protagonist Therapeutics (PTGX) reported operating margin of 20.7% in Q2 2026.
- How has Protagonist Therapeutics's operating margin changed year-over-year?
- Protagonist Therapeutics's operating margin increased by 80.5% year-over-year, from 11.5% to 20.7%.
- What is the long-term trend for Protagonist Therapeutics's operating margin?
- Over 3 years (2021 to 2025), Protagonist Therapeutics's operating margin has grown at a -9.3% compound annual growth rate (CAGR), from -460% to -343.6%.
- What does operating margin mean?
- Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.
Ask your AI about Protagonist Therapeutics's operating margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude